APP and Alzheimer disease: Nevertheless, although these in vivo paradigms are valuable tools to study the molecular mechanisms underlying the AD etiopathogenesis, they do not replicate all aspects of disease’s neuropathology seen in human patients and are quite dissimilar from the most common sporadic forms (sAD) in which no APP overexpression and/or mutation have been reported up to now.